Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - January 2014


CellTech 2014

28 Jan 2014 - 29 Jan 2014 - San Diego, CA, USA



Bookmark and Share


SELECTBIO's CellTech2014 will feature an integrated program of tracks designed to fully describe the latest trends in analysis of cells, cell-based assays and high-content phenotypic assays.

This three-track conference will also feature Flow Cytometry and Bioprocessing, which includes up-stream and down-stream segments.

SELECTBIO's coverage of these topics will include speakers from academic institutions, as well as commercial organisations, in a manner that brings together the basic science with the applications in these three growing market segments.


Agenda Topics:
High Content Screening & Cell Based Assays
•    Advances in Instrumentation & Screening Platforms
•    Cell Based Assays for Conventional & Unconventional Target Interrogation (GPCR, Kinase)
•    High Content Flow Cytometry
•    Phenotypic & Toxicity Cell Based Assays using High Content Approaches
•    Tool Box Availability for Image Processing & Analysis
Cellular Analysis
•    Characterisation of Circulating Tumor Cells
•    Circulating Tumor Cells as Prognostic or Predictive Biomarkers for Cancer
•    Detection, Isolation & Capture of Circulating Tumor Cells
•    Identification & Characterisation of Cancer Stem Cells
•    Role of Cancer Stem Cells in Progression of Disease and Metastasis
Cell Culture & Bioprocessing
•    3D Cell Culture
•    Applications of Cell Culture Technologies
•    Optimising Cell Line Development
•    Preventing Cell Line Cross Contamination
•    Upstream and Downstream BioProcessing for Therapeutic Monoclonal Antibodies and        Recombinant Proteins
•    Vaccine Production Approaches

Also featured will be an exhibition with vendors displaying the most-recent technologies and products in these fields.


Poster Submission Deadline is 10 January 2014

Registration is open – Check out our 2for1 offer – available for a limited time.



Further information
Scientific News
A Gene-Sequence Swap Using CRISPR to Cure Haemophilia
For the first time chromosomal defects responsible for hemophilia have been corrected in patient-specific iPSCs using CRISPR-Cas9 nucleases
Access Denied: Leukemia Thwarted by Cutting Off Link to Environmental Support
A new study reveals a protein’s critical – and previously unknown -- role in the development and progression of acute myeloid leukemia (AML), a fast-growing and extremely difficult-to-treat blood cancer.
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Zebrafish Reveal Drugs that may Improve Bone Marrow Transplant
Compounds boost stem cell engraftment; could allow more matches for patients with cancer and blood diseases.
New Material Forges the Way for 'Stem Cell Factories'
Researchers have discovered the first fully synthetic substrate with potential to grow billions of stem cells. The researchcould forge the way for the creation of 'stem cell factories' - the mass production of human embryonic (pluripotent) stem cells.
Liver Regrown from Stem Cells
Scientists have repaired a damaged liver in a mouse by transplanting stem cells grown in the laboratory.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
'Google Maps' for the Body
Scientists have revealed research that uses previously top-secret technology to zoom through the human body down to the level of a single cell that could be a game-changer for medicine.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!